Menopause Drug Marketer Settles Suit Against Manufacturer
A Canadian company that markets a menopause treatment has reached a £1.7 million ($2.4 million) settlement with a British drugmaker it accused of not fixing cross-contamination problems that held up production...To view the full article, register now.
Already a subscriber? Click here to view full article